14-50324037-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001382507.1(DMAC2L):āc.409C>Gā(p.Gln137Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 1,613,478 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001382507.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DMAC2L | NM_001382507.1 | c.409C>G | p.Gln137Glu | missense_variant | 5/6 | ENST00000557421.7 | NP_001369436.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DMAC2L | ENST00000557421.7 | c.409C>G | p.Gln137Glu | missense_variant | 5/6 | 5 | NM_001382507.1 | ENSP00000506374.1 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 151976Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251106Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135708
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1461502Hom.: 0 Cov.: 30 AF XY: 0.00000550 AC XY: 4AN XY: 727034
GnomAD4 genome AF: 0.000118 AC: 18AN: 151976Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74210
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 30, 2022 | The c.454C>G (p.Q152E) alteration is located in exon 4 (coding exon 4) of the ATP5S gene. This alteration results from a C to G substitution at nucleotide position 454, causing the glutamine (Q) at amino acid position 152 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at